Cancer Cell Paper Identifies “Avidity Enhancement” As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia

Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To “Avidity Enhancement” AMSTERDAM, May 24, 2022 /PRNewswire/ — LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.